BG IRIS Research Client Login
Transactions
Services
Overview
Solutions
Sector expertise
Research
Insights
Overview
White Papers
Blog
Reports
About us
Overview
Senior Team
News
Events
Careers
Overview
Early careers
Experienced hires
Employee Growth Stories
Media
Press
Videos
Contact
Search
BG IRIS Research Client Login
Healthcare
Bryan Garnier & Co advises GeNeuro on its Euronext IPO, raising €33 million, acting as Global Coordinator & Joint Bookrunner
Capital Raise Florealis
Bryan, Garnier & Co announces the successful €25m Placement of Erytech
Bryan Garnier & Co advises DBV Technologies on its follow-on offering, raising $281.5m in July 2015, acting as financial advisor
Bryan, Garnier & Co announces the successful $100m Nasdaq IPO of Celyad.
Bryan, Garnier & Co announces that the total proceeds of Galapagos IPO on Nasdaq, the largest Nasdaq IPO of a European biotech, have been raised to $317m following the full exercise of over-allotment option.
Bryan, Garnier & Co announces the successful follow-on offering of £20m for Advanced Oncotherapy plc
Bryan, Garnier & Co acts as Placement Agent for Nicox €27m Private Placement (PIPE)
Bryan, Garnier & Co acts as Placement Agent for Cardio3 BioScience’s €32m Capital Raise
Bryan, Garnier & Co announces the successful IPO of Bone Therapeutics.
1
…
11
12
13
14
15
…
18
Privacy Preference Center
Privacy Preferences